Real-time monitoring of cardiovascular function in rhesus macaques infected with zaire ebolavirus

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 3, 2011, Pages

  Kortepeter, Mark G ^a,b   Lawler, James V ^c   Honko, Anna ^b   Bray, Mike ^c   Johnson, Joshua C ^b   Purcell, Bret K ^b   Olinger, Gene G ^b   Rivard, Robert ^b   Hepburn, Matthew J ^b   Hensley, Lisa E ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BREATHING RATE; CARDIOVASCULAR FUNCTION; CONFERENCE PAPER; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; FEMALE; FEVER; FLUID THERAPY; HYPOTENSION; KIDNEY FAILURE; LACTIC ACIDOSIS; LETHALITY; MACACA; MALE; MEAN ARTERIAL PRESSURE; MONITORING; NONHUMAN; PRIORITY JOURNAL; PULSE RATE; RASH; SURVIVOR; VIREMIA; ZAIRE EBOLAVIRUS;

ACID-BASE EQUILIBRIUM; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; BLOOD UREA NITROGEN; BODY TEMPERATURE; CATHETERIZATION, CENTRAL VENOUS; CREATININE; EBOLAVIRUS; ELECTROCARDIOGRAPHY; FEMALE; FLUID THERAPY; HEMORRHAGIC FEVER, EBOLA; HYDROGEN-ION CONCENTRATION; HYPOTENSION; KIDNEY; LACTIC ACID; MACACA MULATTA; MALE; RANDOM ALLOCATION; RESPIRATION; RNA, VIRAL; TELEMETRY;

EID: 80054769818     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir337     Document Type: Conference Paper

References (25)

1. WHO. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978; 56:271-93.
2. Kortepeter MG, Bausch D, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 2011; doi: 10.1093/ infdis/jir299.
3. Hensley LE, Young HA, Jahrling PB, Geisbert TW. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 2002; 80:169-79. (Pubitemid 34136004)
4. Mahanty S, Bray M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 2004; 4:487-98. (Pubitemid 39077918)
5. Hensley LE, Jones SM, Feldmann H, Jahrling PB, Geisbert TW. Ebola and Marburg viruses: pathogenesis and development of countermeasures. Curr Mol Med 2005; 5:761-72. (Pubitemid 43009516)
6. Jaax NK, Davis KJ, Geisbert TJ, et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996; 120: 140-55. (Pubitemid 26058522)
7. Geisbert TW, Hensley LE, Jahrling PB, et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 2003; 362:1953-8. (Pubitemid 37548417)
8. Hensley LE, Stevens EL, Yan SB, et al. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis 2007; 196(Suppl 2):S390-9. (Pubitemid 351417286)
9. Geisbert TW, Lee AC, Robbins M, et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 2010; 375: 1896-905.
10. Warren TK, Warfield KL, Wells J, et al. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med 2010; 16:991-4.
11. Connolly BM, Steele KE, Davis KJ, et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis 1999; 179(Suppl 1): S203-17. (Pubitemid 29091404)
12. Bray M, Hatfill S, Hensley L, Huggins JW. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J Comp Pathol 2001; 125:243-53. (Pubitemid 34023737)
13. Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003; 163:2347-70. (Pubitemid 37466478)
14. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999; 179(Suppl 1):S1-7. (Pubitemid 29091373)
15. Ndambi R, Akamituna P, Bonnet MJ, Tukadila AM, Muyembe- Tamfum JJ, Colebunders R. Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(Suppl 1):S8-10.
16. Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ. Development of a preventive vaccine for Ebola virus infection in primates. Nature 2000; 408:605-9.
17. Bente D, Gren J, Strong JE, Feldmann H. Disease modeling for Ebola and Marburg viruses. Dis Model Mech 2009; 2:12-7.
18. Reed DS, Mohamadzadeh M. Status and challenges of filovirus vaccines. Vaccine 2007; 25:1923-34. (Pubitemid 46227672)
19. Ksiazek TG, Rollin PE, Williams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(Suppl 1):S177-87.
20. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78:4330-41. (Pubitemid 38437236)
21. Sanchez A, Wagoner KE, Rollin PE. Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: identification of alleles associated with fatal and nonfatal disease outcomes. J Infect Dis 2007; 196(Suppl 2):S329-36.
22. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med 2003; 31:946-55. (Pubitemid 36379609)
23. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77.
24. Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004; 32: S451-4. (Pubitemid 39489020)
25. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36:222-31.